SAN DIEGO, June 3, 2016 /PRNewswire/ -- aTyr Pharma, Inc.
(Nasdaq: LIFE), a biotherapeutics company engaged in the discovery
and development of Physiocrine-based therapeutics to address severe
rare diseases, today announced the Company's participation at the
Jefferies 2016 Healthcare Conference to be held in New York City from June 7-10, 2016.
The aTyr management team will provide an overview of the Company
during a presentation at 10:30 a.m. ET on Friday, June 10, 2016. The presentation
will be webcast live through the "Investors" section of the aTyr
Pharma website at www.atyrpharma.com. An audio
replay will be available for 30 days following the initial
presentation webcast.
About aTyr Pharma
aTyr Pharma is engaged in the discovery and clinical development
of innovative medicines for patients suffering from severe rare
diseases using its knowledge of Physiocrine biology, a newly
discovered set of physiological modulators. The Company's lead
candidate, Resolaris™, is a potential first-in-class intravenous
protein therapeutic for the treatment of rare myopathies with an
immune component. Resolaris is currently in a Phase 1b/2 clinical
trial in adult patients with facioscapulohumeral muscular dystrophy
(FSHD); a Phase 1b/2 trial in adult patients with limb-girdle
muscular dystrophy 2B (LGMD2B or dysferlinopathies) or FSHD; and a
Phase 1b/2 trial in patients with an early onset form of
FSHD. To protect this pipeline, aTyr built an intellectual
property estate comprising over 70 issued or allowed patents and
over 240 pending patent applications that are owned or exclusively
licensed by aTyr, including over 300 potential Physiocrine-based
protein compositions. aTyr's key programs are currently focused on
severe, rare diseases characterized by immune dysregulation for
which there are currently limited or no treatment options. For more
information, please visit http://www.atyrpharma.com.
Contact:
Mark Johnson
Sr. Director, Investor Relations
mjohnson@atyrpharma.com
858-223-1163
Logo -
http://photos.prnewswire.com/prnh/20120809/MM55538LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/atyr-pharma-to-present-at-jefferies-2016-healthcare-conference-300279257.html
SOURCE aTyr Pharma, Inc.